Jialin Yan

Statistics

Publications

Citations

112

H-Index

Active since

2021

Affiliations

Changsha University of Science and Technology(Current)

University of South China

Capital Medical University

Beijing Anzhen Hospital

Jialin Yan is an author at Changsha University of Science and Technology specializing in p2y12 receptor inhibitors, business, and clinical pharmacology.

ORCID

Publications per year

2021–2024

Publications

Does internal control improve enterprise environmental, social, and governance information disclosure? Evidence from China

Jialin Yan, Haibo Hu, Yiruo Hu · Corporate Social Responsibility and Environmental Management · 2024 · 39 citations · Full text

Business, Accountancy, Corporate Governance +13

Help or hindrance? The impact of female executives on corporate ESG performance in China

Jialin Yan, Yulong Huang, Xiaowei Liao · Journal of Cleaner Production · 2024 · 33 citations

Business, Strategic Management, Strategy +12

Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China

Yi Zhang, Xiujin Shi, Wenxing Peng et al. · Frontiers in Pharmacology · 2021 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial

Xiujin Shi, Yunnan Zhang, Yi Zhang et al. · Frontiers in Cardiovascular Medicine · 2021 · 12 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–4 of 4